Mirae Asset Global Investments’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Mirae Asset Global Investments’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,524	Closed	-$263K	–	515
2015 Q1	$263K	Buy	+1,524	New	+$224K	0.01%	421
2014 Q4	–	Sell	-1,520	Closed	-$237K	–	497
2014 Q3	$237K	Buy	+1,520	New	+$220K	0.01%	434

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Mirae Asset Global Investments's SLXP Position: Q2 2015 in Review

Mirae Asset Global Investments sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 1,524 shares — an estimated $263K sold.

Mirae Asset Global Investments first reported a position in SLXP in Q3 2014 and held it in 2 quarters. The position peaked at $263K in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Mirae Asset Global Investments reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Mirae Asset Global Investments sold 1,524 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $263K.
Mirae Asset Global Investments first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2014 and held it in 2 quarters.
Mirae Asset Global Investments's SALIX PHARMACEUTICALS LTD DEL position peaked at $263K in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Mirae Asset Global Investments's 13F filing for Q2 2015, filed 14 Aug 2015.